23.1. Analysis.
Comparison 23 Topical calcineurin inhibitors: tacrolimus 0.1% ointment versus vehicle, Outcome 1 Primary: investigator‐rated good/excellent control of symptoms.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.